Background: Diabetes-specific formulas (DSF) are designed to improve glycemic control in people with diabetes. We evaluated the relationships between study participant characteristics and impact on postprandial glycemic (PPG) response of Glucerna® formulas, other DSF, and typical foods consumed by adults with type 2 diabetes.

Methods: Fasting plasma glucose and PPG response data were extracted for analysis from 10 randomized, placebo-controlled, crossover studies conducted between 2003 and 2010. Interventions included Glucerna® formulas (Abbott Nutrition, Columbus, Ohio, U.S.), other non-Abbott DSF, and typical foods (oatmeal and a standard high carbohydrate breakfast). First period data for maximal change from baseline for glucose were analyzed for sex, body mass index (BMI), and A1c.

Results: A total of 505 participants were included in the analysis (median age, 59 years; median BMI, 31.7 kg/m2; and median A1c, 7.3%). Compared to other DSF and to food, Glucerna products elicited an improved PPG response (mean + standard error of the mean. Glucerna: 2.18 + 0.10 mmol/L; other DSF: 3.38 + 0.24 mmol/L, p<0.0001; foods: 2.98 + 0.21 mmol/L, p=0.0001). Glucerna products produced an improved PPG response compared to other DSF in overweight (p=0.002) and obese (p=0.0001) subjects. Among subjects with A1c < 7.3%, there was a trend for a better PPG response than among subjects with A1c > 7.3%, regardless of treatment (p=0.05).

Conclusions: Glucerna products elicited a better PPG response compared to other DSF and selected foods in adults with type 2 diabetes irrespective of sex, age or BMI. There appears to be variability in PPG responses to Glucerna and other DSF in overweight and obese adults with type 2 diabetes; this variability could be due to differences in nutrient composition and ingredients.

Disclosure

C.J. Alish: Employee; Self; Abbott Laboratories.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.